Sex |
Female |
170 (43.0) |
Male |
225 (57.0) |
Functional status |
Normal activity |
178 (45.1) |
Symptoms but ambulatory |
150 (37.9) |
Confined to bed or chair <50% of waking hours |
44 (11.1) |
Confined to bed or chair ≥50% of waking hours |
20 (5.1) |
Completely disabled—100% bedridden |
3 (0.8) |
Type of lung cancer |
Squamous cell carcinoma |
77 (19.5) |
Adenomatous carcinoma |
164 (41.5) |
Other non–small cell carcinoma |
67 (17.0) |
Small cell carcinoma |
58 (14.7) |
Unknown |
29 (7.3) |
Treatment |
Surgery with/without chemotherapy/radiation therapy |
113 (28.6) |
Chemotherapy and/or radiation therapy |
254 (64.3) |
No treatment |
28 (7.1) |
Metastases |
Present at baseline |
128 (32.4) |
Found during follow-up |
37 (9.4) |
None |
230 (58.2) |
Cancer stage |
Stage I |
56 (14.2) |
Stage II |
33 (8.3) |
Stage III |
119 (30.1) |
Stage IV |
133 (33.7) |
Not confirmed |
54 (13.7) |
Age, years |
63.4 ± 9.5 (31–88) [64] |
Education, years |
10.9 ± 3.9 (2–24) [11] |
Intervals in care |
Investigation to diagnosis, weeks |
5.6 ± 8.0 (0–78) [3] |
Diagnosis to first treatment, days |
29.0 ± 26.6 (0–140) [21] |